The use of engineered E1A genes to transactivate the hCMV-MIE promoter in permanent CHO cell lines.

od Cockett, M I, Bebbington, C R, Yarranton, G T
Izdano 1991

Detection of the catalytic activities of DNA polymerases and their associated exonucleases following SDS-polyacrylamide gel electrophoresis.

od Spanos, A, Sedgwick, S G, Yarranton, G T, Hübscher, U, Banks, G R
Izdano 1981

Codon usage can affect efficiency of translation of genes in Escherichia coli.

od Robinson, M, Lilley, R, Little, S, Emtage, J S, Yarranton, G, Stephens, P, Millican, A, Eaton, M, Humphreys, G
Izdano 1984

Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab́ fragments

od Casey, J L, Pedley, R B, King, D J, Green, A J, Yarranton, G T, Begent, R H J
Izdano 1999

Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab' fragment.

od King, D J, Adair, J R, Angal, S, Low, D C, Proudfoot, K A, Lloyd, J C, Bodmer, M W, Yarranton, G T
Izdano 1992

Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.

od Casey, J. L., King, D. J., Chaplin, L. C., Haines, A. M., Pedley, R. B., Mountain, A., Yarranton, G. T., Begent, R. H.
Izdano 1996

Expression, purification and characterization of B72.3 Fv fragments.

od King, D J, Byron, O D, Mountain, A, Weir, N, Harvey, A, Lawson, A D, Proudfoot, K A, Baldock, D, Harding, S E, Yarranton, G T
Izdano 1993

Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM).

od Antoniw, P., Farnsworth, A. P., Turner, A., Haines, A. M., Mountain, A., Mackintosh, J., Shochat, D., Humm, J., Welt, S., Old, L. J., Yarranton, G. T., King, D. J.
Izdano 1996

Tumour targeting of humanised cross-linked divalent-fab′ antibody fragments: a clinical phase I/II study

od Casey, J L, Napier, M P, King, D J, Pedley, R B, Chaplin, L C, Weir, N, Skelton, L, Green, A J, Hope-Stone, L D, Yarranton, G T, Begent, R H J
Izdano 2002